Trevi Therapeutics (TRVI)
(Delayed Data from NSDQ)
$2.75 USD
+0.14 (5.36%)
Updated Aug 15, 2024 04:00 PM ET
After-Market: $2.73 -0.02 (-0.73%) 7:58 PM ET
4-Sell of 5 4
D Value F Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/14/2024
Time: -- |
9/2024 | $-0.12 | 0.00% |
Earnings Summary
For their last quarter, Trevi Therapeutics (TRVI) reported earnings of -$0.12 per share, missing the Zacks Consensus Estimate of -$0.11 per share. This reflects a negative earnings surprise of 9.09%. Look out for TRVI's next earnings release expected on November 14, 2024. For the next earning release, we expect the company to report earnings of -$0.12 per share, reflecting a year-over-year decrease of 50%.
Earnings History
Price & Consensus
Zacks News for TRVI
Why Trevi Therapeutics (TRVI) Stock Might be a Great Pick
TRVI: What are Zacks experts saying now?
Zacks Private Portfolio Services